Thermo Fisher Scientific Inc.
TMO Healthcare Diagnostics & Research
Thermo Fisher Scientific Inc.’s revenue for fiscal 2025 (year ended December 2025) was $44.6 billion, up 3.91% from fiscal 2024. In the quarter to June 2026, revenue grew 10.5%, EPS grew 9.35%, free cash flow grew 51.8% and total debt rose 18.7%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.
Follow TMO
Thermo Fisher Scientific Inc. (TMO) EV/FCF
As of 16 October 2026, Thermo Fisher Scientific Inc. (TMO) trades at a EV/FCF of 39.5×. Over the past ten years it has ranged from 23.1× (June 2021) to 44.9× (April 2023); the current reading is higher than 89% of that period.
EV/FCF, daily
Embed this chart
Annual newest first
| Period | EV/FCF | Change |
|---|---|---|
| FY2025 | 38.5× | 27.01% |
| FY2024 | 30.3× | (8.77%) |
| FY2023 | 33.3× | (2.78%) |
| FY2022 | 34.2× | (19.89%) |
| FY2021 | 42.7× | 50.78% |
| FY2020 | 28.3× | (20.05%) |
| FY2019 | 35.4× | 28.66% |
| FY2018 | 27.5× | 2.88% |
| FY2017 | 26.8× | 6.53% |
| FY2016 | 25.1× | (5.69%) |
Quarterly newest first
| Period | EV/FCF | Change |
|---|---|---|
| Jun 2026 | 30.0× | (7.17%) |
| Mar 2026 | 32.4× | (16.04%) |
| Dec 2025 | 38.5× | 11.88% |
| Sep 2025 | 34.4× | 19.09% |
| 42 more quarters | Free account |
Against its own ten years
EV/FCF against peers
| Company | EV/FCF |
|---|---|
| IQV IQVIA Holdings Inc. compare | 25.8× |
| DHR Danaher Corporation compare | 33.2× |
| IDXX IDEXX Laboratories, Inc. compare | 36.0× |
| TMO Thermo Fisher Scientific Inc. | 39.5× |
| A Agilent Technologies, Inc. compare | 39.9× |
| MTD Mettler-Toledo International, Inc. compare | 40.2× |
| ILMN Illumina, Inc. compare | 44.1× |
| WAT Waters Corporation compare | 129× |
| NTRA Natera, Inc. compare | 658× |
What EV/FCF is
EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))
More on TMO
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement